ANTHEM logo

Anthem Biosciences LTD

ANTHEM·NSE·
923.85 +30.80 (+3.45%)
Market Cap51954.73 Cr
PE Ratio87.65
Volume11,90,354
Day High - Low939.00 - 893.20
52W High-Low942.60 - 579.15
DocStoX Score
6.5/10
Fair
Fair Value
Sign in to see
ROE
22.30%
Strong
P/E
87.65x
Expensive
Debt / Equity
0.02
Low
Industry
Healthcare
Biotechnology
Overall View
Mixed

Price performance

NIFTY 500NIFTY MIDCAP 150
Day893.20
939.00
52W579.15
942.60
DocStoX take

Supported by quality (9.1) and risk (9.1), but held back by valuation (0.0). Quality looks strong at 9.1, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.5
/10
Fair
Quality
Excellent
ROE 22.3%
Valuation
Expensive
P/E 87.7×
Growth
Steady
Revenue +14.0% 5Y CAGR
Risk
Low risk
D/E 0.02
Momentum
Strong
95% of 52-week range

At a glance

Market Cap
₹51,955 Cr
52W High / Low
₹943 / ₹579
Dividend Yield
0.22%
Promoter Holding
71.42%
EPS (TTM)
₹10.54
Book Value
₹54.20

Key highlights

  • Capital works hard — ROCE 30%
  • Low leverage — D/E 0.02
  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
  • Expensive at 88× earnings
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Biotechnology

ANTHEM BIOSCIENCES LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.